Photothermally activatable semiconducting polymeric pro-agonist in second near-infrared window for photothermal immunotherapy. 10.1038/s41467-021-21047-0 #cancerresearch https://t.co/4zRawjN2tn
Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Feb 2021 – Jun 2023Where it's discussed
-
X / Twitter6 posts
-
YouTube1 videos
AI synopsis
What people are saying
The discussions highlight excitement about the novel use of NIR-II light for precise cancer treatment, with phrases like 'photothermal immunotherapy' and 'nanoagonist' indicating interest in the technology's potential. The tone reflects both appreciation for the scientific advancement and anticipation of clinical impact, emphasizing the importance of the work for cancer research and nanomedicine.
Most posts express support or approval of the publication's innovative approach and findings.
Posts demonstrate high curiosity, emphasizing the novelty and potential of NIR-II activated nanoagents.
Discussions include technical details such as references to photothermal effects and immune activation, indicating thoughtful engagement.
Posts suggest that this research could significantly influence future cancer therapies and nanomedicine development.
Abstract in brief
- The study introduces a new polymer nanoagonist called APNA, which is activated by second near-infrared (NIR-II) light to enable precise, controllable cancer immunotherapy through combined photothermal effects and immune activation.
- APNA is designed with a thermoresponsive linker that, when exposed to NIR-II irradiation, causes tumor ablation and releases an immunostimulant directly within deep tissue tumors, effectively stimulating local and systemic immune responses.
- This method enhances immune cell infiltration in both the primary tumor and distant metastases, like the lung and liver, demonstrating a promising strategy for targeted, spatiotemporal cancer treatment with minimized side effects.]
Top posts
Most liked on X and BlueskyRT @NatureComms: Photothermally activatable semiconducting polymeric pro-agonist in second near-infrared window for photothermal immunother…
#Nanomedicine: researchers synthesized polymer nanoagonists that can be activated by second near-infrared photothermia to trigger the liberation of immunostimulants. The nanoagents could help design new photothermal immunotherapies for #cancer treatment - https://t.co/uEUVSUKevU https://t.co/rKzSAX4hB5
RT @NatureComms: Photothermally activatable semiconducting polymeric pro-agonist in second near-infrared window for photothermal immunother…
Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer https://t.co/0unREdhjGQ
Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer. https://t.co/VR202WgVTw https://t.co/PvOSjJkFLa
All mentions
Polymer Nanoagonist for NIR-II Photothermal Cancer Immunotherapy
This study introduces APNA, a polymer nanoagonist activated by second near-infrared light to enable precise cancer immunotherapy through combined photothermal effects and immune activation, stimulating immune responses…
Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer. https://t.co/VR202WgVTw https://t.co/PvOSjJkFLa
RT @NatureComms: Photothermally activatable semiconducting polymeric pro-agonist in second near-infrared window for photothermal immunother…
RT @NatureComms: Photothermally activatable semiconducting polymeric pro-agonist in second near-infrared window for photothermal immunother…
Photothermally activatable semiconducting polymeric pro-agonist in second near-infrared window for photothermal immunotherapy. 10.1038/s41467-021-21047-0 #cancerresearch https://t.co/4zRawjN2tn
#Nanomedicine: researchers synthesized polymer nanoagonists that can be activated by second near-infrared photothermia to trigger the liberation of immunostimulants. The nanoagents could help design new photothermal immunotherapies for #cancer treatment - https://t.co/uEUVSUKevU https://t.co/rKzSAX4hB5
Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer https://t.co/0unREdhjGQ